SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Motorola Solutions, Inc. engages in the provision of communication infrastructure, devices, accessories, software, and services. It operates through the Products and Systems Integration and Software and Services segments. The Products and Systems Integration segment includes a portfolio of infrastructure, devices, accessories, and video security devices, and the implementation and integration of such systems, devices, and applications. The Software and Services segment focuses on the public safety and enterprise Command Center Software, unified communications applications, and video software solutions. The company was founded on September 25, 1928 and is headquartered in Chicago, IL.

Motorola Solutions Inc

MSI is trending due to mixed sentiment after its earnings report, with some traders pointing to institutions adding put protection despite accumulating shares. The community is debating whether the stock is oversold and poised for a reversal, while others cite large dark pool prints and potential accumulation as bullish signals. Upgrades from analysts may also be contributing to the increased attention on the stock.

Aimei Health Technology Co., Ltd. is a blank check company, which engages in entering a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. The company was founded on April 27, 2023 and is headquartered in New York, NY.

Aimei Health Technology Co Ltd

Aimei Health Technology ($AFJK) is trending due to a massive price surge, with some comparing it to other recent high-flying stocks. The community is actively discussing whether it's a pump and dump or a legitimate opportunity, with many noting its low float and high volatility. Some traders suggest the move is fueled by institutional holders, while others point to potential scams associated with similar Chinese stocks.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Denver, CO.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir $PLTR is trending amid news of a $448M Navy contract for its ShipOS AI platform, intended to modernize submarine maintenance. Community discussions revolve around the potential impact on revenue and global expansion, with some questioning the valuation and others remaining strongly bullish. Broader conversations touch on Palantir's growing presence in corporate America and the implications of government contracts.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending as investors discuss the potential impact of US and EU initiatives to secure rare earth element supply chains, highlighted by a recent joint venture with Romania, designed to challenge China's dominance. Community discussions revolve around the significance of these developments for CRML, particularly regarding future funding, off-take agreements, and the upcoming Bank Feasibility Study (BFS). The broader context includes the increasing geopolitical importance of rare earth elements and their role in military and technological applications.

Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.

Enveric Biosciences Inc

Enveric Biosciences is trending due to recent attention on its low float and potential for a short squeeze, with some traders drawing comparisons to other high-momentum stocks. Community members are discussing the company's intellectual property and ongoing patent litigation related to AbbVie's acquisition, speculating on a possible settlement. The stock's volatile history, including reverse splits and public offerings, is also a key point of discussion among investors.

Horizon Space Acquisition I Corp. operates as a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on June 14, 2022 and is headquartered in New York, NY.

Horizon Space Acquisition I Corp

HSPO is seeing significant volatility and increased trading volume, with community members pointing to a potential short squeeze and comparing it to other recent high-flying stocks. However, news of the company's planned delisting from the Nasdaq is also circulating, creating uncertainty around the stock's future. Some traders are discussing both long and short strategies, while others warn of potential risks.

Oriental Culture Holding Ltd. operates as a holding company, which is engaged in providing collectibles and artwork e-commerce services through its subsidiaries. The firm facilitates trading by individual customers of all kinds of collectibles, artwork, and certain commodities on its online platform owned by its subsidiary in Hong Kong, namely the China International Assets and Equity of Artworks Exchange Limited. It provides services including investor education, market information, customer support, and technology infrastructure. The company was founded in March 2018 and is headquartered in Hong Kong.

Oriental Culture Holding Ltd

OCG is experiencing significant volatility and trending due to a massive volume spike and price surge, with community members discussing quick in-and-out trades and potential for further gains. The stock's movement is being compared to other recent high-flying tickers, with some cautioning about potential risks associated with Chinese stocks. A possible merger and reverse split approval are also being discussed as potential catalysts.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals ($ARWR) is trending due to positive analyst ratings, pipeline progress, and upcoming catalysts, including a potential FDA approval. The community is discussing the company's RNAi platform, potential market opportunities, and the possibility of a buyout. Bullish sentiment surrounds Arrowhead's diverse pipeline and potential for significant growth in the pharmaceutical sector.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending amid speculation about a potential deal with Warner Bros. Discovery, with community chatter focusing on a possible bidding war with Paramount and the deal's potential impact. Some traders believe the stock is oversold and due for a bounce, while others express concern about the financial implications of acquiring WBD and the potential for regulatory hurdles.

Cantor Equity Partners, Inc. is a blank check company, which engages in the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 11, 2020 and is headquartered in New York, NY.

Twenty One Capital Inc. - Ordinary Shares- Class A

Twenty One Capital Inc

Twenty One Capital ($XXI) is trending as traders discuss its significant Bitcoin holdings and potential valuation relative to its market cap. Community members are debating the share structure, float, and possible short squeeze opportunities. The stock's correlation to Bitcoin's price movements and recent CEO appearances are also fueling interest.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Carisma Announces Delisting from Nasdaq and SEC Deregistration

Carisma Announces Delisting from Nasdaq and SEC Deregistration Carisma Announces Delisting from Nasdaq and SEC Deregistration PR Newswire PHILADELPHIA, Dec. 5, 2025 PHILADELPHIA, Dec. 5, 2025...

JPM downgrades Avis Budget after stock rally on recall, tariff impact

Investing.com -- JP Morgan downgraded  Avis Budget  (NASDAQ:CAR) Group to Neutral from Overweight, saying the stock’s sharp rally since March has outpaced the underlying earnings outlook, while near-term pressures from safety recalls and fading tariff tailwinds weigh on estimates.

These companies are most likely to surprise in real estate H1 earnings season

Investing.com -- Bernstein expects a mixed but potentially positive first-half earnings season for the European real estate sector, highlighting nine companies that could raise their guidance.

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference

Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference Carisma Therapeutics to Participate in H.C. Wainwright 3rd Annual Cell Therapy Virtual Conference PR...

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference

Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference Carisma Therapeutics to Participate in Oppenheimer 35th Annual Healthcare Life Sciences Conference...

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline

Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline PR Newswire PHILADELPHIA, Dec. 9...

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting 2024

Carisma Therapeutics Presents Promising New Preclinical Data on Engineered Macrophages for the Treatment of Liver Fibrosis at AASLD The Liver Meeting 2024 Carisma Therapeutics Presents Promising New...

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR...

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024

Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024 Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for...

Carisma Therapeutics Announces Changes to its Board of Directors

Carisma Therapeutics Announces Changes to its Board of Directors Carisma Therapeutics Announces Changes to its Board of Directors PR Newswire PHILADELPHIA, Oct. 30, 2024 Appointment of Sohanya Cheng...

Carisma Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of immunotherapies. It offers chimeric antigen receptor (CAR)-macrophages, a cell therapy platform focusing on the treatment of solid tumors. The company was founded by Michael Klichinsky and Saar Gill in April 2016 and is headquartered in Philadelphia, PA.

Current Price	$0.0678
Prev Close	$0.0492
Open	$0.0509
Dividend Yield	0.00%
50-Day Moving Average	$0.085
Beta	0.93
Avg. Volume	314,885.68
PE Ratio	0.36

52-Week High	$1.27
52-Week Low	$0.0261
Market Capitalization	$2.06M
EPS (Annual)	-$1.46
Price to Book	-3.27
Revenue Per Employee	$426,782.61
Enterprise Value/EBITDA	N/A

CARM
Carisma Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CARM News

CARMCarisma Therapeutics Inc